Giulia pasello

[Stephen V Liu, MD @StephenVLiu]

An audit of the biomarkers ATLAS project (https://t.co/zEioWMyr2d) is available @LungCaJournal. A knowledge-based database integrating clinical and molecular records from 80 referral Italian institutions led by Dr. @UmbertoMalapel1.

https://t.co/lCMYQr9dyG

[Lauren Meehan Machos, MPH @LaurenMachos]

@giuliapasello @JessicaJLinMD @peters_solange discussing resistance in targeted therapies, sequencing, toxgmt, development of nextgen tx options in biomarker driven NSCLC
#ELCC24 #lcsm #alk

[Noemi Reguart @NReguart]

🏅🎖️This year, the best poster of the category NSCLC METASTATIC #ESMO2023 goes to Thiago Madeira @ThiagoMadeiraa and his mentor @MaysaVilbert exploring RW neurocognitive AEs related to lorlatinib in ALK and ROS + NSCLC. Congratulations!!!

[Giulia pasello @giuliapasello]

https://t.co/3AEXUBiA0x

[Giulia pasello @giuliapasello]

https://t.co/ddsLuw3k9k

[Stephen V Liu, MD @StephenVLiu]

We love our #ASCO23 host @marinagarassino! @EnriquetaFelip @peters_solange @delvysra @HendriksLizza @HwakeleeMD @PrelajArsela @ClaudiaProto @rossana_berardi @giuliapasello @LuisPaz_Ares @MartinReck2 @NReguart @a_dingemans @ChristianRolfo @JustinGainor @dplanchard @charocampelo

[Gaia Griguolo @GaiaGriguolo]

Starting the second day of the @iov_irccs Retreat!
Sharing science for the benefit of our patients
@valeguarneri @FedeMiglietta @giuliapasello

[Stephen V Liu, MD @StephenVLiu]

Adjuvant therapy session at #RomeLung22 highlights include Dr. Yi Long Wu discussing adjuvant #EGFR therapy, Dr. @EnriquetaFelip reviewing atezolizumab, Dr. @giuliapasello on canakinumab, and Dr. Simon Ekman on other checkpoint inhibitors. Important to choose the right path!

[AIRO Lung @AiroLung]

I Venerdì di AIRO: webinar su nuove evidenze e temi scottanti in radio-oncologia toracica nel trattamento del NSCLC stadio III
8 aprile 14.30-16.30
https://t.co/AhJaNOdYqe
@AndrearicFili @PaoloBorghetti2 @ALESSIOBRUNI10 @giuliapasello @serenabadellino @stefanovagge @airo_young

[Federica Grosso @fedgrosso]

#w4oitaly #women4oncology la slide presentata da LLicitra che ha caratterizzato un momento topico della sua carriera

[valentina @valeguarneri]

#w4oitaly

[Vanessa Pavinato @Vpavinato]

First day, #W4Oitaly: crowded room, enthusiastic participation #women4onco@GarassinoMarina @grikamartinelli @myESMO

[W4O_Italy @w4o_italy]

Primo corso di #w4oitaly. Due giorni, 50 oncologhe e tanto entusiasmo! @marinagarassino @grikamartinelli @myESMO

[Vanessa Pavinato @Vpavinato]

Body language session right now at #w4oitaly https://t.co/XWrknWMr1v #women4onco https://t.co/xU4VsHWWLj

[Giulia pasello @giuliapasello]

#women4onco #w4oitaly

[Fabio Puglisi @puglisi_fabio]

Looking at the dark side is the best way to shed light on the evidence

[ONcotwITting @ONcotwITting]

#ASCO15 Brividi in plenaria: combinazione magica di nivolumab e ipilimumab per il trattamento del melanoma avanzato http://t.co/yc3Qg5dFoq

[The ASCO Post @ASCOPost]

Discussing Child’s Cancer Prognosis Beneficial for Parents http://t.co/42v2i2TBUD #pedcsm #ASCO15

[ONcotwITting @ONcotwITting]

Il sorpasso è compiuto: il tumore del polmone prima causa di morte oncologica anche nelle ... http://t.co/eYOGE1VliR

[Samantha Cristoforetti @AstroSamantha]

Good night from #space. Buona notte dallo spazio.